Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric Mass”

3,475 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,475 results

Not applicableStudy completedNCT02454647
What this trial is testing

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Who this might be right for
Gastric CancerAdenocarcinomaEffects of Chemotherapy+2 more
Clinica Universidad de Navarra, Universidad de Navarra 46
Testing effectiveness (Phase 2)Looking for participantsNCT05769725
What this trial is testing

Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer

Who this might be right for
Serplulimab,Gastric Cancer, Adjuvant Therapy
RenJi Hospital 70
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Large-scale testing (Phase 3)UnknownNCT02409199
What this trial is testing

Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Carcinoma
Shanghai Zhongshan Hospital 66
Not applicableStudy completedNCT04901585
What this trial is testing

Enterotomy Closure and Minimally Invasive Gastrectomy

Who this might be right for
Gastric Cancer
Federico II University 600
Large-scale testing (Phase 3)Not Yet RecruitingNCT06768164
What this trial is testing

Quality of Life After Billroth II or Roux-en-Y for Gastric Cancer

Who this might be right for
Gastric (Cardia, Body) Cancer
Assistance Publique - Hôpitaux de Paris 250
Early research (Phase 1)WithdrawnNCT00429078
What this trial is testing

Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer

Who this might be right for
Gastric Cancer
Roger Williams Medical Center
Testing effectiveness (Phase 2)UnknownNCT00270543
What this trial is testing

An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms
Far Eastern Memorial Hospital 54
Testing effectiveness (Phase 2)Looking for participantsNCT05671822
What this trial is testing

Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer

Who this might be right for
HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 258
Not applicableUnknownNCT05165602
What this trial is testing

Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System

Who this might be right for
HER2 Positive Gastric Cancer
Peking University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04902872
What this trial is testing

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
Solid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more
Cybrexa Therapeutics 130
Testing effectiveness (Phase 2)UnknownNCT04943653
What this trial is testing

Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Stomach NeoplasmsPaclitaxelPeritoneal Metastases
Seoul St. Mary's Hospital 61
Testing effectiveness (Phase 2)Looking for participantsNCT07176312
What this trial is testing

Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

Who this might be right for
Gastroesophageal AdenocarcinomaFirst Line TherapyHER2 + Gastric Cancer+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 80
Not applicableUnknownNCT05390684
What this trial is testing

Predictive Model to Early Diagnosis of Anastomotic Leak After Esophagectomy and Gastrectomy.

Who this might be right for
Esophagus CancerGastric CancerLeak, Anastomotic+1 more
Hospital Universitario La Fe 800
Not applicableActive Not RecruitingNCT07184047
What this trial is testing

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersFrailtySarcopenia in Elderly+8 more
Ankara Etlik City Hospital 72
Testing effectiveness (Phase 2)Study completedNCT00375999
What this trial is testing

Docetaxel and Epirubicin in Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Yonsei University 34
Not applicableEnded earlyNCT00923052
What this trial is testing

The Natural History of Solid Organ Cancer Stem Cells (SOCSC)

Who this might be right for
Hepatic CancerPancreatic Ductal CancerColorectal Cancer+2 more
National Cancer Institute (NCI) 190
Testing effectiveness (Phase 2)UnknownNCT02177552
What this trial is testing

Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma

Who this might be right for
Esophageal NeoplasmsStomach Neoplasms
Rigshospitalet, Denmark 98
Not applicableUnknownNCT03085199
What this trial is testing

Laparoscopic Reinforcement Suture (LARS) of Duodenal Stump A Prospective Single Arm Phase II Study

Who this might be right for
Duodenal Stump Leak
Inje University 100
Very early researchUnknownNCT06098898
What this trial is testing

Safety and Efficacy of NK510 to Treat Gastric Cancer

Who this might be right for
Gastric Cancer
Base Therapeutics (Shanghai) Co., Ltd. 9
Load More Results